Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

[ad_1] Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting…

Pfizer moves forward with once-daily version of weight loss pill after setbacks

[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…

Investors want proof AI will aid drug discovery. Evidence may come in the second half

[ad_1] As investors peer into the future to envision which industries are ripe to be reshaped…

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…

Supreme Court blocks Purdue Pharma opioid settlement, threatening billions of dollars for victims

[ad_1] WASHINGTON — The Supreme Court on Thursday blew up the massive bankruptcy reorganization of opioid…

Walgreens stock plunges as drugstore chain slashes profit guidance in ‘challenging’ consumer environment

[ad_1] In an aerial view, a customer enters a Walgreens store on January 04, 2024 in…

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers

[ad_1] US President Joe Biden speaks during an event at the National Institutes of Health (NIH)…

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

[ad_1] Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for…

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

[ad_1] Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug…

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…